Automated Release Testing System (ARTS) (ARTS)
Description
Acthera Therapeutics AG and ZHAW propose to build an Automated Release Testing System(ARTS) for mechanotherapeutic drugs. The device is important for Acthera for testing new drugliposome formulations, controlling quality, keeping an edge over competition and collaborating with regulatory bodies.
Key Data
Projectlead
Deputy Projectlead
Project team
Project partners
Acthera Therapeutics AG
Project status
completed, 10/2021 - 09/2023
Funding partner
Innovationsprojekt / Projekt Nr. 56587.1 IP-LS
Project budget
448'584 CHF
